DICER1 and B-cell non-Hodgkin lymphoma: Hematopoietic cells, such as B cells, are highly sensitive to loss of Dicer and quickly go through apoptosis, which implies Dicer as a potential therapeutic target for controlling certain hematopoietic malignancies like the B cell lymphoma (Adams and Eischen, 2014).